1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Cardiovascular Devices Market Trends
  5. > Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

REPORT DESCRIPTION

Global Market Watch:
BRICSS Coronary Stents market value is expected to reach US$1 billion by 2016, primarily supported by the product types - Drug Eluting Stents, Bare Metal Stents, Absorbable Stents and …etc. China accounts for nearly 28% of the market share and India claims more than 23%. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Among the product types, Drug Eluting Stents account more nearly half of the market value while Absorbable Stents segments indicate a close 14%. In case of Stent Coating, Polymer depicts the largest CAGR while Non-Polymer and Inorganic in second and third place respectively.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

Report Focus:
The report ‘Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report primarily focuses on:

- Emerging Market Trends
- Advancements in the Technological Space
- Market Demand of The Segments (By-Region)
- Key Growth Areas and Market Size
- Region-Wise Demand Factor
- Key Competitors Edge
- Investment Strategies

The analysis primarily deals with by type & stent coating. Further, the subdivided categories include:
Coronary Stents – By Type & Stent Coating
- By Type
a. Drug-Eluting Stents (DES)
b. Bare Metal Stents (BMS)
c. Absorbable Stents/Biodegradable Metallic Stent
d. Anti-Restenosis Devices
i. Bioactive Stent
ii. Radioactive Stent
iii. Drug-Eluting Balloon
- By Stent Coating
a. Inorganic (PERSE, Gold, Silicon Carbide, Iridium Oxide, Carbon, Titanium-Nitride-Oxide)
b. Polymer (Biodegradable & Non-Biodegradable)
c. Non-Polymer (Microporous, Microstructured, Slotted Tubular, Nanoporous, Nanopatterned)
d. Other Coatings (Heparin, Hyaluronic Acid, Fibrin), Technologies & R&D

The period considered for the coronary stents market analysis is 2012-2018. The region wise distribution of the market consists of BRICSS (Brazil, Russia, India, China, South Korea and South Africa).

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 138 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

Table Of Contents

Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018
TABLE OF CONTENTS
I. REPORT FOCUS
A. INTRODUCTION

CARDIOLOGY

KINDS OF CARDIAC CONDITIONS
A. BLOOD FLOW IN THE HEART

B. HEART MALFUNCTION
TYPES OF CARDIAC ARREST

C. MYOCARDIUM
DISORDERS OF MYOCARDIUM

D. PERICARDIUM

E. HEART VALVES
DISORDERS OF HEART VALVES

F. CONGENITAL HEART DEFECT
TYPES OF CONGENITAL HEART DEFECT

G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES)

H. HEART FAILURE

B. CARDIOVASCULAR DEVICES
DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT
TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME
TOOLS DEPLOYED IN CARDIOLOGY
DIAGNOSTIC TESTS AND PROCEDURES
CONCLUSION

C. INTERVENTIONAL CARDIOLOGY

A. INTERVENTIONAL DIAGNOSTICS AND ITS TECHNOLOGIES
I. INTRAVENOUS ULTRASOUND (IVUS)
II. OPTICAL COHERENCE TOMOGRAPHY (OCT)
III. FRACTIONAL FLOW RESERVE (FFR) - A BIG TECHNOLOGICAL BREAKTHROUGH
IMPLICATIONS OF FFR GROWTH - FALL IN USE OF GUIDEWIRES AND DES IN PATIENTS WITH MULTIVESSEL STENOSES
FFR HAS GREATER IMPACT ON THE GLOBAL MARKET IN THE LONG TERM
EMERGING RIVAL TECHNOLOGIES: CT-FFR AND IFR
THE RESULTS OF A CLINICAL TRIAL COMPARING IFR TO FFR
PERCUTANEOUS CORONARY INTERVENTION (PCI)

B. INTERVENTIONAL CARDIAC DEVICES
CORONARY STENTS

ADVANCES IN STENT TECHNOLOGY: EXPECTATIONS AND NEW DEVELOPMENTS
STENT SCAFFOLD STRUCTURE

CORONARY STENT COATING TYPES - IN BRIEF
TYPES OF STENT COATINGS, IN BRIEF:-

A. INORGANIC COATINGS
GOLD
SILICON CARBIDE
IRIDIUM OXIDE
CARBON
TITANIUM-NITRIDE-OXIDE

B. POLYMER COATINGS
NON-BIODEGRADABLE POLYMERS
BIODEGRADABLE POLYMERS

C. NON-POLYMER COATINGS/SURFACES:
MICROPOROUS SURFACES
MICROSTRUCTURED SURFACES
SLOTTED TUBULAR SURFACES
NANOPOROUS SURFACES
NPS
NANO-PATTERNED SURFACES

D. OTHER COATINGS/STRATEGIES
HEPARIN
HYALURONIC ACID (HA)
FIBRIN
ENDOTHELIAL CELLS (EC)
CONCLUSION

CARDIAC STENT USAGE IN THE US
PROCEDURES PERFORMED
PREFERRED STENT TYPE
STENT FACTORS AND THE IMPORTANCE OF VENDOR RELATIONSHIPS

A. DRUG-ELUTING STENTS (DES)
DIAGNOSTICS LIKELY TO CHANGE DES USAGE
INTRAVENOUS DIAGNOSTICS: THE FUTURE GATEKEEPER FOR STENT USAGE
DES: THE NEXT TARGET FOR MEDICAL SPENDING CUTS
DES AT THE FOREFRONT OF PRICE CUTS AND USAGE LIMITATION
ASIAN-BORN INNOVATION TO TARGET A DECLINING DES MARKET IN FUTURE
THE BEST STENTS AVAILABLE IN MARKET AND INNOVATIONS ARE ON THE WAY
GROWTH TREND OF ASIAN COMPANIES COMPARABLE TO US COMPANIES' IN THE LATE 90'S
US AND JAPAN BREAKDOWN OF PCI CASES
GLOBAL DRUG-ELUTING STENT MARKET LIKELY TO DECLINE
NEXT GENERATION STENTS - BVS, SYNERGY, TCD-10023 AND BIOFREEDOM
FIRST-GENERATION STENTS
SECOND-GENERATION STENTS
THIRD-GENERATION STENTS

B. BARE METAL STENTS (BMS)
BARE-METAL AND DRUG-ELUTING STENTS MARKET

C. ABSORBABLE STENTS/BIODEGRADABLE METALLIC STENT
BIOABSORBABLE STENT SCAFFOLDS
SELF-EXPANDING STENT SCAFFOLDS
MICROMESH COVERED STENT
DEDICATED BIFURCATION STENTS
SPECULATION ON BIO-ABSORBABLE STENTS

D. ANTI-RESTENOSIS DEVICES
VASCULASTâ„¢ - DRUG ELUTING COATING
COVIDIEN COMMENCES PATIENT ENROLMENT IN ANTI-RESTENOSIS STUDY
DRUG ELUTING BALLOONS
CONCLUSION

NEW DIRECTIONS FOR STENT TECHNOLOGY
STRONG GROWTH EXPECTED FOR BIOABSORABLE STENTS IN EUROPE, UNITED STATES
BIOSENSORS, ABBOTT, ART EMERGE AS BIOABSORABLE STENT COMPETITORS
BIFURCATED STENTS TO ENTER THE U.S. MARKET, EUROPEAN MARKET SEES DOUBLE DIGIT GROWTH

D. CORONARY STENTS - TYPES and STENT COATING - MARKET BRIEFING
CHINA
INDIA
BRAZIL
RUSSIA
SOUTH KOREA
SOUTH AFRICA

II. MARKET ANALYSIS
CORONARY STENTS - BRICSS - INDUSTRY SNAPSHOT

A. CORONARY STENTS - SEGMENTATION
CORONARY STENTS - GLOBAL
CORONARY STENTS - BRICSS

CORONARY STENTS - BY TYPE
CORONARY STENTS - BRICSS - BY TYPE
DRUG-ELUTING STENTS (DES)
BARE METAL STENTS (BMS)
ABSORBABLE STENTS
ANTI-RESTENOSIS DEVICES

CORONARY STENTS - BY STENT COATING
CORONARY STENTS - BRICSS - BY STENT COATING
INORGANIC COATING
POLYMER COATING
NON-POLYMER COATING
OTHER STENT COATINGS

B. GROWTH RATE ANALYSIS
BRICSS CORONARY STENTS - MARKET GROWTH RATES
BRICSS CORONARY STENTS - TYPE - GROWTH RATES
BRICSS CORONARY STENTS - STENT COATING - GROWTH RATES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW
FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
AN ENCOURAGING JAB FOR TORPID PERIODS

A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
CARDIAC RHYTHM MANAGEMENT DEVICES
CRM IN EUROPE

CARDIAC DEFIBRILLATORS
RAPID GROWTH IN DEFIBRILLATOR SALES

CARDIAC PACEMAKER DEVICES
THE DATA COLLECTION WORK

CARDIAC RESYNCHRONIZATION THERAPY (CRT)

CARDIAC MONITORING AND DIAGNOSTIC DEVICES
THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS
INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET
THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW

INTERVENTIONAL CARDIAC DEVICES
CORONARY STENTS
EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION

FFR IMPACT ON DES MARKET
MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET

CARDIAC CATHETERS
COMPETITIVE ANALYSIS

ELECTROPHYSIOLOGY CATHETERS (EP)
GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE
DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH

EP MAPPING
NEW AF ABLATION DEVICES SEEK APPROVAL

ATRIAL FIBRILLATION (AF)

INTRAVASCULAR ULTRASOUND (IVUS)
GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS

PERIPHERAL VASCULAR DEVICES
ARTERIOTOMY CLOSURE DEVICES
EMBOLIC PROTECTION DEVICES (EPD)
INFERIOR VENA CAVA (IVC) FILTERS
CONCLUSION

PERIPHERAL GUIDEWIRES
AV ACCESS THROMBECTOMY DEVICES

PROSTHETIC HEART VALVES
SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW
MARKET CHALLENGES

B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE
DRIVERS IN THE MEDICAL IMPLANT INDUSTRY
SIZE AND WEIGHT
POWER EFFICIENCY
PERFORMANCE SPECIFICATIONS
RISK MITIGATION AND RELIABILITY
EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES

C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE
CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY
IMPACT OF CVD IN EUROPE
IMPACT ON NEW YORK STATE
ECONOMIC IMPACT OF CVD IN NYS
HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION
IMPACT OF CVD ON ECONOMIC STABILITY

ECONOMIC COST OF CARDIOVASCULAR DISEASES

COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030

CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE

D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND

E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES

F. MARKET TRENDS
PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL
CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS
GE HEALTHCARE'S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS
GE'S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.
CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE
INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)
TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS
INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS
STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)
VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION
GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL
MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES
B. BRAUN'S INTROCAN SAFETY® 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD
MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING
RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH
A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN
ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY
SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE.
FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK'S NEW EVIA HF-T PACEMAKER.
AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL
SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS
USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS
MORTARA INSTRUMENT, INC. LAUNCHES “BUILT WITH PRIDE IN MILWAUKEE” CAMPAIGN.
MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT
DRUG-ELUTING STENTS ARE SECURE
CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE'S USER SATISFACTION SURVEY
ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME
ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT
ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE.
BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENTâ„¢ SOLUTIONS.
HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS
FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK
FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE “MOST ADMIRED COMPANY”
BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE
COOK MEDICAL TO INVEST €16.5M IN IRISH MEDICAL TECHNOLOGY MARKET
MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE
MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA.
NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY—INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH
FIRST IMPLANT OF BOSTON SCIENTIFIC'S WATCHMAN® DEVICE IN PATIENTS IN LATIN AMERICA
STUDY REVEALS THAT BAYER HEALTHCARE'S COTAVANCE® DRUG ELUTING BALLOONS WITH PACCOCATH® TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS.
USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS
SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011
TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY
CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL
SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC)
EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES.
ZOLL NOMINATED TO GLOBE 100 AGAIN
USCOM ENTERS EUROPEAN MARKETS
POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS
USCOM SECURES STRONG PRESENCE IN US AND CANADA
CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES
COVIDIEN INTRODUCES NEW GLOBAL PACKAGING
STENTYS'S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY.
SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT
CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD
USCOM EYES EASTERN EUROPEAN MARKET
VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART
INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES
INFECTIONS FROM IMPLANTED CARDIAC DEVICES
TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION
HEART TRANSPLANTS SUBSTITUTED BY A PUMP
DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF)
REMOTE MONITORING OF HEART FAILURE PATIENTS
EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES
OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION
IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH
OVER-THE-COUNTER APPARATUS
BOSTON SCIENTIFICS' IMPLANTABLE DEFIBRILLATOR
CARDIAC SCIENCE'S NEW CARDIAC TREATMENT
THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION
CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD
LOCAL MEDICARE'S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY
A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION
A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC
LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA
INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS
BEST AND LATEST SELF-TEACHING HEART SOUNDS
REPLACING VALVE WITHOUT CARDIAC SUPPORT
U.S. FDA GRANTS THE NAVISTAR® THERMOCOOL CATHETER FOR RAPID HEART BEAT
AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES
NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA
MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS

G. KEY COMPANY PROFILES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES

CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS

CARDIAC MEDICAL DEVICES - PATENTS

KEY COMPANIES FINANCIAL OVERVIEW

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX
RESEARCH FOCUS
ABOUT AXIS RESEARCH MIND
DISCLAIMER
FEEDBACK
LIST OF TABLES/CHARTS
I. REPORT FOCUS
1. COMPARISON PCI GUIDELINE IN US AND EU FOR IVUS/OCT/FFR
2. LIST OF DEDICATED CORONARY BIFURCATION STENTS
3. CURRENTLY AVAILABLE BARE-METAL CORONARY STENT SYSTEMS
4. BIOABSORBABLE SCAFFOLDS (ADVANTAGES AND DISADVANTAGES)
5. LIST OF BIOABSORBABLE STENTS WITH CHARACTERISTICS AND CLINICAL EVIDENCE
6. CONTEMPORARY DRUG ELUTING BALLOONS

D. CORONARY STENTS - TYPES and STENT COATING - MARKET BRIEFING
CHINA
7. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR CHINA - (2012-2018, IN USD$ MILLION)
8. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF CHINESE MARKET VALUE - (2015 - 2018)
9. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR CHINA - (2012-2018, IN USD$ MILLION)
10. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF CHINESE MARKET VALUE - (2015 - 2018)

INDIA
11. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR INDIA - (2012-2018, IN USD$ MILLION)
12. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF INDIAN MARKET VALUE - (2015 - 2018)
13. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR INDIA - (2012-2018, IN USD$ MILLION)
14. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF INDIAN MARKET VALUE - (2015 - 2018)

BRAZIL
15. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR BRAZIL - (2012-2018, IN USD$ MILLION)
16. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF BRAZILIN MARKET VALUE - (2015 - 2018)
17. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR BRAZIL - (2012-2018, IN USD$ MILLION)
18. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF BRAZILIN MARKET VALUE - (2015 - 2018)

RUSSIA
19. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR RUSSIA - (2012-2018, IN USD$ MILLION)
20. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF RUSSIAN MARKET VALUE - (2015 - 2018)
21. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR RUSSIA - (2012-2018, IN USD$ MILLION)
22. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF RUSSIAN MARKET VALUE - (2015 - 2018)

SOUTH KOREA
23. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR SOUTH KOREA - (2012-2018, IN USD$ MILLION)
24. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF SOUTH KOREAN MARKET VALUE - (2015 - 2018)
25. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR SOUTH KOREA - (2012-2018, IN USD$ MILLION)
26. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF SOUTH KOREAN MARKET VALUE - (2015 - 2018)

SOUTH AFRICA
27. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
28. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF SOUTH AFRICAN MARKET VALUE - (2015 - 2018)
29. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
30. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF SOUTH AFRICAN MARKET VALUE - (2015 - 2018)

31. CORONARY STENTS - PRODUCT BY BRANDS

II. MARKET ANALYSIS
32. BRICSS CORONARY STENTS - SEGMENTATION BY TYPES

CORONARY STENTS - GLOBAL
33. CORONARY STENTS MARKET - GLOBAL CURRENT TRENDS, ESTIMATES and FORECASTS - (2012-2018, IN USD$ MILLION)

CORONARY STENTS - BRICSS
34. CORONARY STENTS MARKET - BRICSS CURRENT TRENDS, ESTIMATES and FORECASTS - (2012-2018, IN USD$ MILLION)
35. CORONARY STENTS MARKET - BRICSS CURRENT TRENDS, ESTIMATES and FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
36. CORONARY STENTS MARKET - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

CORONARY STENTS - BY TYPE
37. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR BRICSS CURRENT TRENDS, ESTIMATES and FORECASTS - (2012-2018, IN USD$ MILLION)
38. CORONARY STENTS - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF BRICSS MARKET VALUE - (2015-2018)

CORONARY STENTS - BRICSS - BY TYPE
DRUG-ELUTING STENTS (DES)
39. DRUG-ELUTING STENTS (DES) MARKET - BRICSS CURRENT TRENDS, ESTIMATES and FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
40. DRUG-ELUTING STENTS (DES) - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

BARE METAL STENTS (BMS)
41. BARE METAL STENTS (BMS) MARKET - BRICSS CURRENT TRENDS, ESTIMATES and FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
42. BARE METAL STENTS (BMS) - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

ABSORBABLE STENTS
43. ABSORBABLE STENTS MARKET - BRICSS CURRENT TRENDS, ESTIMATES and FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
44. ABSORBABLE STENTS - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

ANTI-RESTENOSIS DEVICES
45. ANTI-RESTENOSIS DEVICES MARKET - BRICSS CURRENT TRENDS, ESTIMATES and FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
46. ANTI-RESTENOSIS DEVICES - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

CORONARY STENTS - BY STENT COATING
47. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR BRICSS CURRENT TRENDS, ESTIMATES and FORECASTS - (2012-2018, IN USD$ MILLION)
48. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF BRICSS MARKET VALUE - (2015-2018)

CORONARY STENTS - BRICSS - BY STENT COATING
INORGANIC COATING
49. INORGANIC MARKET - BRICSS CURRENT TRENDS, ESTIMATES and FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
50. INORGANIC - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE -
(2015-2018)

POLYMER COATING
51. POLYMER MARKET - BRICSS CURRENT TRENDS, ESTIMATES and FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
52. POLYMER - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

NON-POLYMER COATING
53. NON-POLYMER MARKET - BRICSS CURRENT TRENDS, ESTIMATES and FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
54. NON-POLYMER - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

OTHER STENT COATINGS
55. OTHER COATINGS MARKET - BRICSS CURRENT TRENDS, ESTIMATES and FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
56. OTHER COATINGS - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

B. GROWTH RATE ANALYSIS
BRICSS CORONARY STENTS - MARKET GROWTH RATES
57. CORONARY STENTS MARKET - BRICSS - % GROWTH RATE FORECASTS - (2012-2018)

BRICSS CORONARY STENTS - TYPE - GROWTH RATES
58. CORONARY STENTS - TYPES - % GROWTH RATE FORECASTS FOR DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - (2012-2018)

BRICSS CORONARY STENTS - STENT COATING - GROWTH RATES
59. CORONARY STENTS - STENT COATING - % GROWTH RATE FORECASTS FOR INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - (2012-2018)

C. INVESTMENT FOCUS
61. CORONARY STENTS - FORECASTED CAGR% - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
61. CORONARY STENTS - TYPES - DRUG ELUTING STENTS, BARE METAL STENTS, ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - FORECASTED CAGR% - VALUE - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
62. CORONARY STENTS - COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER and RandD - FORECASTED CAGR% - VALUE - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL

III. INDUSTRY OVERVIEW
63. INTRAVENOUS DIAGNOSTICS - BY TYPE - FFR - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES and FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
64. INTRAVENOUS DIAGNOSTICS - BY TYPE - OCT - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES and FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
65. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2010, IN USD BILLION)
66. PROJECTED TOTAL COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2015-2030, IN USD BILLION)
67. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASE BY AGE - (2012, IN USD BILLION)
68. PROJECTIONS OF CRUDE CARDIOVASCULAR DISEASE PREVALENCE - (% - 2010-2030) IN THE UNITED STATES
69. PROJECTED DIRECT MEDICAL COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
70. PROJECTED INDIRECT LOST PRODUCTIVITY COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
71. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2014
72. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2013
73. WORLDWIDE KEY PLAYERS INTO CARDIOVASCULAR DEVICES INDUSTRY THAT PROJECT IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE
74. COVERAGE OF CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
75. CARDIAC ARRHYTHMIAS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
76. CIRCADIAN RHYTHM SLEEP DISORDERS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME - 2014
77. PERIPHERAL VASCULAR DISEASE (PVD) DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
78. ANNUAL SALES OF CARDIAC THERAPY PRODUCTS MARKETED BY THERAPY AREA - (2010-2012, IN US$ MILLION)
79. ABIOMED, INC. - PRODUCT REVENUE, FOR 2011-2013 (IN US$ '000)
80. ACCELLENT, INC. - NET REVENUE, FOR 2011 AND 2012 (IN US$ '000)
81. ALERE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)
82. AMBU A/S, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 and 2013 (IN DKK MILLION)
83. ANGIODYNAMICS, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 and 2013 (IN USD$ '000)
84. ATRICURE, INC. - NET SALES BY PRODUCT IN DOMESTIC and INTERNATIONAL AND GEOGRAPHY, FOR 2012 and 2013 (IN US$ '000)
85. BAXTER INTERNATIONAL, INC. - NET SALES BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 and 2013 (IN USD$ MILLION)
86. BECTON, DICKINSON and CO - NET SALES BY MARKET SEGMENT, FOR 2011-2013 (IN USD$ MILLION)
87. BIOHEART, INC. - NET SALES, FOR 2011-2013 (IN US$ '000)
88. BIOSENSORS INTERNATIONAL GROUP, LTD. - NET SALES REVENUE BY MARKET SEGMENT, LICENSING AND GEOGRAPHY, FOR 2012 and 2013 (IN US$ '000)
89. BIOTELEMETRY, INC. - NET SALES REVENUE AND GROSS PROFIT, FOR 2011-2013 (IN US$ '000)
90. BOSTON SCIENTIFIC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN USD$ MILLION)
91. C. R. BARD, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
92. CARDICA, INC. - NET REVENUE, FOR 2011-2013 (IN US$ '000)
93. COMPUMED. INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 IN USD
94. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT and GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
95. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT, FOR USA AND NON-USA FOR 2011-2013 (IN US$ MILLION)
96. CONMED CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
97. CRYOLIFE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
98. CRYOLIFE, INC. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
99. DELTEX MEDICAL GROUP PLC - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ '000)
100. DIGIRAD CORPORATION - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
101. DRÄGER MEDICAL AG and CO. KG - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 (IN US$ 'MILLION)
102. EDWARDS LIFESCIENCES LLC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ 'MILLION)
103. ENDOLOGIX, INC, - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
104. HEARTWARE, LTD. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
105. HOSPIRA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
106. INDRAPRASTHA APOLLO HOSPITAL - NET REVENUE, FOR 2012-2013 (IN INDIAN RUPEES)
107. INSPIREMD, LTD. - NET REVENUE, FOR 2012-2013 (IN US$ '000)
108. JOHNSON and JOHNSON - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
109. KONINKLIJKE DSM N.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 IN (EURO MILLION)
110. LOMBARD MEDICAL TECHNOLOGIES PLC - NET REVENUE, FOR 2011-2013 (IN US$ '000)
111. OPTO CIRCUITS (INDIA) LIMITED - NET REVENUE BY CONSOLIDATED AND STANDALONE, FOR 2011-2013 (IN INDIAN RUPEES)
112. MICROPORT MEDICAL (SHANGHAI) CO. LTD - NET REVENUE, FOR 2012 AND 2013 SIX MONTHS ENDED 30TH JUNE (IN RMB'000)
113. ST. JUDE MEDICAL, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (US$ IN MILLION)
114. TTK - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN INDIAN RUPEES)
115. CARDIUM THERAPEUTICS, INC. - NET REVENUE, FOR 2012-2013 ENDED FOR NINE MONTHS (IN US$ MILLION)
116. MERIT MEDICAL SYSTEMS, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ '000)
117. SPECTRANETICS INTERNATIONAL B.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
118. VARIAN MEDICAL - NET REVENUE BY MARKET AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
119. TELEFLEX MEDICAL - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, FOR 2011-2013 (IN US$ MILLION)
120. ABBOTT VASCULAR DEVICES - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
121. MEDTRONIC, INC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2012 (IN US$ MILLION)
122. AORTECH INTERNATIONAL PLC - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ '000)
123. VOLCANO CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 and 2012 (IN US$ '000)
124. PHILIPS MEDICAL SYSTEMS - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 and 2012 (IN US$ '000)
125. ATCOR MEDICAL HOLDINGS LIMITED - NET REVENUE BY GEOAGRAPHY, FOR 2012 AND 2013 (IN US$ MILLION)
126. LIDCO GROUP PLC - NET REVENUE BY PRODUCTS AND GEOGRAPHY, FOR 2011-2013 (IN GBP£ '000)
127. SORIN GROUP USA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, 2011-2013 (IN EURO MILLION)
128. THORATEC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 and 2012 (IN US$ '000)
129. STEREOTAXIS, INC. - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2011 and 2012 (IN USD)
130. F.HOFFMANN-LA ROCHE LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN CHF MILLION)
131. PULSION MEDICAL SYSTEMS SE - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2012-2013 (IN EURO '000)
132. NOVADAQ TECHNOLOGIES INC - NET REVENUE BY CATEGORY AND GEOGRAPHY, FOR 2011-2013 (IN USD)
133. SIEMENS MEDICAL SOLUTIONS USA, INC. - NET REVENUE BY GEOGRAPHY AND MARKET SEGMENT, FOR 2012 AND 2013 (IN € MILLION)
134. FUKUDA DENSHI CO. LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN MILLION YEN)
135. NIHON KOHDEN CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN MILLION YEN)
136. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 AND 2012 (IN YUAN)
137. ASAHI KASEI CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN ‘¥' YEN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
European Market Report for Dialysis Catheters 2017 - MedCore

European Market Report for Dialysis Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European market for dialysis catheters comprises the acute hemodialysis, chronic hemodialysis and peritoneal dialysis catheter segments. The chronic hemodialysis catheter market is segmented ...

Vascular Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

Vascular Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

Vascular Access Devices Market: Scope and Methodology Vascular access devices are medical devices used to obtain access to the bloodstream, and are hollow and flexible tubes made of latex, silicone, and ...

Czech Republic Interventional Cardiology Market Outlook to 2022

Czech Republic Interventional Cardiology Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Czech Republic Interventional Cardiology Market Outlook to 2022 Summary GlobalData’s new report, Czech Republic Interventional Cardiology Market Outlook to 2022, provides key market data on the Czech ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.